Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
In an interview with 60 Minutes, the Federal Trade Commission head said the agency believes it has the authority to ban ...
FTC Chair Lina Khan said in a "60 Minutes" interview that hundreds of acquisitions by Big Tech players like Facebook led to ...
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
Grocery chains Kroger and Albertsons want to merge. It's a move Federal Trade Commission Chair Lina Khan worries could hurt ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
At this week’s National Advertising Division Annual Conference, FTC Commissioner Melissa Holyoak and FTC Bureau of Consumer Protection Director ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback